Source: StreetInsider

Press Release: Stentys : STENTYS: Failure of the search for a strategic partner

STENTYS (Paris: STNT) (FR0010949404 - STNT), a French group specialized in medical technologies for interventional cardiology, today announces that its search for a strategic partner has failed and the Board of Directors has decided to ask its shareholders to vote on the dissolution of the Company.

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
Christophe Lottin's photo - CEO of Stentys

CEO

Christophe Lottin

CEO Approval Rating

74/100

Read more